[ad_1]
“Illegal access” to BioNTech documents during a cyber attack
| Reading time: 2 minutes
The European Medicines Agency has been the target of a cyber attack
What: REUTERS
According to BioNTech and Pfizer, documents about the coronavirus vaccine were accessed from pharmaceutical companies in a hacker attack on the European Medicines Agency. The company’s shares fell.
reThe European Medicines Agency (EMA) has been attacked by cybercriminals. “Some documents related to the submission of approvals for Pfizer and BioNTech’s Covid-19 candidate vaccine BNT162b2,” BioNTech said Wednesday night are affected. There was an “illegal access”. There is no evidence that patient data is affected.
According to the EMA, the incident will have no impact on the vaccine’s examination deadlines. Pfizer confirmed the information. The EMA had previously announced the hacker attack without giving details first. It is in charge of evaluating and controlling drugs.
BioNTech and Pfizer shares fell as much as 3.5 percent on Wall Street. In recent months, there had already been several attacks on research institutions and companies in relation to Covid-19 vaccines; Hackers from Russia, China and North Korea are said to have participated in some cases.
The EMA is currently targeting approval of the BioNTech vaccine by the end of December, for a Moderna agent in mid-January. EMA experts have already analyzed vast amounts of data from the companies’ pretests in recent months, Emer Cooke, head of the authority, said earlier this month.
British health authorities have already granted emergency approval for the corona vaccine from Mainz-based pharmaceutical company BioNTech and its US partner Pfizer. People in Britain have been immunized en masse since Tuesday.
Also in Canada, health authorities gave the green light to the active ingredient in BioNTech and Pfizer on Wednesday. The vaccine had undergone accelerated testing while it was still in clinical trials. Meets “stringent safety, efficacy and quality requirements for use in Canada”. A statement from BioNTech said that at least 20 million doses of vaccine would be delivered to Canada over the next year.
Meanwhile, Israel received the first vaccine doses of the active ingredient BioNTech-Pfizer. These first cans arrived on Wednesday aboard a DHL cargo plane at Tel Aviv’s Ben Gurion Airport, which was greeted by Prime Minister Benjamin Netanyahu. He announced that he wanted to be the “first” to get vaccinated to be a “role model.”
